학술논문
Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With Crohn’s Disease in the CELEST Extension Study
Document Type
Article
Author
Source
In Clinical Gastroenterology and Hepatology October 2022 20(10):2337-2346
Subject
Language
ISSN
1542-3565